Biological basis for anti-angiogenic therapy, 8-10 November 1999, Milan, Italy.
Meade-Tollin
L C
LC
University of Arizona, College of Medicine, Section of Surgical Research, Tucson 85724, USA. glato@azstarnet.com
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D016228:Endothelial Growth Factors / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D008222:Lymphokines / Q000502:physiology / Q000627:therapeutic use; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000473:pathology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors